Furthermore, PFK1 O-GlcNAcylation increases NADPH and GSH levels in cancer cells, and similarly to G6PD, PFK1 O-GlcNAcylation affords a growth advantage to tumor cells [312]. Here, PFKM is linked to neoplasm.